ANNX+22.70%20.0%
BHVN-30.76%20.0%
DNLI+15.46%20.0%
KYMR+91.69%20.0%
VRTX+21.31%20.0%
As of Oct 9, 2026, 4:27 AM ET
Rare Diseases '25: CNS/Neuro Constituents
Annexon, Inc.ANNX | 20.0% | -0.25% | -0.25% | -8.47% | -2.91% | -20.32% | -28.57% | 104.08% | 22.70% | -41.94% | -80.18% | $655.4M |
Biohaven Ltd.BHVN | 20.0% | 0.42% | -10.10% | -20.47% | -9.21% | 5.67% | 3.56% | -49.62% | -30.76% | -77.72% | 63.42% | $1.80B |
Denali Therapeutics Inc.DNLI | 20.0% | -2.56% | -11.01% | -13.44% | -9.06% | 13.08% | -11.85% | 35.88% | 15.46% | -30.15% | -63.33% | $2.96B |
Kymera Therapeutics, Inc.KYMR | 20.0% | 0.88% | -2.41% | -5.31% | -0.74% | 40.47% | 19.65% | 314.64% | 91.69% | 153.95% | 96.58% | $8.99B |
Vertex Pharmaceuticals IncorporatedVRTX | 20.0% | -0.47% | -4.63% | -3.43% | -0.69% | 11.00% | 1.29% | 4.09% | 21.31% | 9.65% | 181.24% | $127.73B |
| Theme return | — | -0.40% | -5.68% | -12.08% | -5.15% | 15.96% | 0.19% | 74.12% | 38.66% | -3.43% | 98.98% | — |
| Average | 20.0% | -0.40% | -5.68% | -10.22% | -4.52% | 9.98% | -3.18% | 81.81% | 24.08% | 2.76% | 39.55% | $28.43B |
| Median | 20.0% | -0.25% | -4.63% | -8.47% | -2.91% | 11.00% | 1.29% | 35.88% | 21.31% | -30.15% | 63.42% | $2.96B |
| Std Dev | 0.0% | 1.18% | 4.22% | 6.14% | 3.85% | 19.38% | 16.16% | 126.59% | 39.15% | 80.58% | 98.81% | $49.73B |
| Min | 20.0% | -2.56% | -11.01% | -20.47% | -9.21% | -20.32% | -28.57% | -49.62% | -30.76% | -77.72% | -80.18% | $655.4M |
| Max | 20.0% | 0.88% | -0.25% | -3.43% | -0.69% | 40.47% | 19.65% | 314.64% | 91.69% | 153.95% | 181.24% | $127.73B |
| % Positive Tickers | 40.00% | 0.00% | 0.00% | 0.00% | 80.00% | 60.00% | 80.00% | 80.00% | 40.00% | 60.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondaryWgt ↓ · Scroll right · Tap headers to sort